Dr Henry Carleton

Medical Doctor, now Healthtech entrepreneur focused on solutions to deliver sustainable healthcare at scale

📍 United Kingdom🔄 Updated September 2026💼 1 investments📅 8 years investing🗓 Last invested Sep 2018
Operator-angel🌍 United Kingdom
1
Total investments
0
Early stage
0
Mid stage
1
Late stage
8y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Board Advisor
Sep 2018
We’re working for a world where no one dies from skin cancer by deploying our AI medical device, DERM, to create the world’s most advanced skin cancer pathways. Skin Analytics are proud to work with NHS dermatology teams to deploy AI powered skin cancer pathways. Our pathways enable NHS organisations to discharge benign lesions earlier in the pathway and therefore tackle backlog, free up out-patient delays and crucially, reserve limited dermatology capacity to prioritise patients with skin cancer by focusing on providing potentially life-saving treatment. Some things we’re a little bit proud of: 🚀We’ve deployed with 18 NHS partners across primary and secondary care since 2020 🥇We’re the first and only AI skin cancer pathway within the NHS ✅DERM is the only Class IIa UKCA marked and Class III CE marked AI as a Medical Device for skin cancer 🤯DERM is used in pathways that have seen over 135,000 NHS patients and identified more than 13,000 cancers 💪We’ve helped NHS organisations avoid up to 95% of face-to-face appointments in secondary care 🤳We provide Bupa and Vitalitys remote skin assessment service ❤️Everything we do is in pursuit of better patients outcomes that are sustainable for health systems, globally
Experience · 4 entries
All (4)
Investments (1)
Founder (3)
2018
Investor & Board Advisor
Sep 2018
We’re working for a world where no one dies from skin cancer by deploying our AI medical device, DERM, to create the world’s most advanced skin cancer pathways. Skin Analytics are proud to work with NHS dermatology teams to deploy AI powered skin cancer pathways. Our pathways enable NHS organisations to discharge benign lesions earlier in the pathway and therefore tackle backlog, free up out-patient delays and crucially, reserve limited dermatology capacity to prioritise patients with skin cancer by focusing on providing potentially life-saving treatment. Some things we’re a little bit proud of: 🚀We’ve deployed with 18 NHS partners across primary and secondary care since 2020 🥇We’re the first and only AI skin cancer pathway within the NHS ✅DERM is the only Class IIa UKCA marked and Class III CE marked AI as a Medical Device for skin cancer 🤯DERM is used in pathways that have seen over 135,000 NHS patients and identified more than 13,000 cancers 💪We’ve helped NHS organisations avoid up to 95% of face-to-face appointments in secondary care 🤳We provide Bupa and Vitalitys remote skin assessment service ❤️Everything we do is in pursuit of better patients outcomes that are sustainable for health systems, globally
2014
Co Founder & Managing Director
Feb 2014
Four Eyes Insight helps healthcare organisations identify and realise the true productivity potential of their operational and clinical teams. Our approach identifies, targets and rectifies those well-known, but difficult to sort, operational challenges that routinely frustrate managers and clinicians. We use best practice knowledge, honed from delivering many successful improvement programmes across the NHS, to support service providers in structuring and delivering optimal clinical services. Our teams use a combination of expert engagement, comprehensive analytics and operational improvement tools to support clinical and managerial teams in delivering higher levels of productivity. Although known for being the Market leader in delivering operating theatre productivity, we offer support to a much wider portfolio of clinical delivery areas including; Outpatients, Cath Labs, Endoscopy and Clinical Productivity Specialty Deep Dives. Our most recent development gaining significant interest and engagement is our work with Sustainability and Transformation Partnerships (STPs) in understanding their clinical delivery capacity and productivity potential. Our comprehensive offering also includes INSIGHT our artificial intelligence scheduling and theatre planning tool. Insight is a cloud-based software that uses data analysis and system integration to predict, generate and deploy optimised operating theatre capacity. The theatre module is the first module of our AI clinical services business planning solutions. So, if you are looking for targeted professional services support to kick start your clinical productivity improvement ambitions or seeking an artificially intelligent software response to planning your elective delivery capabilities, or a combination of both, then Four Eyes Insight is here to help.
2010
Co Founder & Non-Executive Director
Aug 2010
Kendall Bluck Consulting is a unique company consisting of a clinician-led healthcare consultancy, executive coaching and leadership development, outsourced medical staffing services, education and learning consultancy, and non-clinical healthcare research. The experience within the team covers Acute Hospitals, Strategic Health Authorities, Primary Care Trusts, community services, private healthcare consultancy, education and local government. In addition to our core team, we have a large pool of clinical and non-clinical experts and affiliates who add specialist subject matter knowledge and expertise to our projects. Vision Inspiring Exceptional Performance in Healthcare. Values Relationships – we build relationships with our clients so they can explore, support and own the study, in order to promote sustainable change. Change – we help our clients build awareness of the wider system so they can promote engagement and address the inevitable barriers to change, to bring about service transformation. Curiosity – we challenge our clients to look beyond the obvious, so they can unlock opportunities for improvement and drive innovation. Continual Improvement – we provide on-going support to our clients to review progress and identify best practice, to demonstrate improved service delivery and performance.
2000
Co Founder and Managing Director
Oct 2000